Compare, Analyse ASTRAZENECA PHARMA with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ASTRAZENECA PHARMA vs TEVA PHARMA (Israel) - Comparison Results

ASTRAZENECA PHARMA     Change

AstraZeneca Pharma India Limited (APIL) is a 90% subsidiary of the UK based AstraZeneca Pharmaceuticals, which is one of the world's leading pharma companies. APIL has interests in the six crucial areas of cardiovascular, respiratory, maternal health... More

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 ASTRAZENECA PHARMA   TEVA PHARMA
EQUITY SHARE DATA
    ASTRAZENECA PHARMA
Mar-18
TEVA PHARMA
Dec-13
ASTRAZENECA PHARMA/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs1,2783,147-   
Low Rs8832,734-   
Sales per share (Unadj.) Rs228.41,806.2-  
Earnings per share (Unadj.) Rs10.4112.8-  
Cash flow per share (Unadj.) Rs16.3258.8-  
Dividends per share (Unadj.) Rs098.77-  
Dividend yield (eoy) %03.4 0.0%  
Book value per share (Unadj.) Rs98.82,006.4-  
Shares outstanding (eoy) m25.00848.00-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.71.6 290.5%   
Avg P/E ratio x104.226.1 400.0%  
P/CF ratio (eoy) x66.411.4 584.8%  
Price / Book Value ratio x10.91.5 746.3%  
Dividend payout %087.5 0.0%   
Avg Mkt Cap Rs m27,0082,493,629 1.1%   
No. of employees `0001.444.9 3.0%   
Total wages/salary Rs m1,5350-   
Avg. sales/employee Rs Th4,210.934,078.9 12.4%   
Avg. wages/employee Rs Th1,132.20-   
Avg. net profit/employee Rs Th191.12,128.9 9.0%   
INCOME DATA
Net Sales Rs m5,7101,531,676 0.4%  
Other income Rs m1230-   
Total revenues Rs m5,8331,531,676 0.4%   
Gross profit Rs m463419,450 0.1%  
Depreciation Rs m147123,807 0.1%   
Interest Rs m030,085 0.0%   
Profit before tax Rs m438265,559 0.2%   
Minority Interest Rs m01,206 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-174,325 0.0%   
Tax Rs m179-3,242 -5.5%   
Profit after tax Rs m25995,683 0.3%  
Gross profit margin %8.127.4 29.6%  
Effective tax rate %40.8-1.2 -3,345.5%   
Net profit margin %4.56.2 72.6%  
BALANCE SHEET DATA
Current assets Rs m3,2091,034,488 0.3%   
Current liabilities Rs m2,070902,161 0.2%   
Net working cap to sales %20.08.6 231.0%  
Current ratio x1.61.1 135.2%  
Inventory Days Days7291 79.7%  
Debtors Days Days3596 36.4%  
Net fixed assets Rs m790500,279 0.2%   
Share capital Rs m503,770 1.3%   
"Free" reserves Rs m2,4190-   
Net worth Rs m2,4691,701,401 0.1%   
Long term debt Rs m0783,180 0.0%   
Total assets Rs m4,6053,500,370 0.1%  
Interest coverage xNM9.8-  
Debt to equity ratio x00.5 0.0%  
Sales to assets ratio x1.20.4 283.3%   
Return on assets %5.63.6 156.6%  
Return on equity %10.55.6 186.6%  
Return on capital %17.74.9 359.7%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m-1,7150-   
CASH FLOW
From Operations Rs m88244,070 0.0%  
From Investments Rs m-94-86,484 0.1%  
From Financial Activity Rs mNA-292,778 0.0%  
Net Cashflow Rs m-6-135,192 0.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 75.4 Rs / USD

Compare ASTRAZENECA PHARMA With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  

Compare ASTRAZENECA PHARMA With: AUROBINDO PHARMA  UNICHEM LAB  STRIDES PHARMA SCIENCE  DR. DATSONS LABS  DISHMAN PHARMA  



Today's Market

Volatile Day for Indian Indices: Sensex Ends 131 Points Lower Post Rebound; Telecom and Auto Stocks Bleed(Closing)

It was a volatile day for India share markets today. The benchmark indices opened higher but turned volatile.

Related Views On News

ASTRAZENECA PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 236.5% (Quarterly Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

For the quarter ended June 2019, ASTRAZENECA PHARMA has posted a net profit of Rs 215 m (up 236.5% YoY). Sales on the other hand came in at Rs 2 bn (up 26.7% YoY). Read on for a complete analysis of ASTRAZENECA PHARMA's quarterly results.

ASTRAZENECA PHARMA Announces Quarterly Results (4QFY19); Net Profit Up 204.9% (Quarterly Result Update)

May 27, 2019 | Updated on May 27, 2019

For the quarter ended March 2019, ASTRAZENECA PHARMA has posted a net profit of Rs 98 m (up 204.9% YoY). Sales on the other hand came in at Rs 2 bn (up 26.3% YoY). Read on for a complete analysis of ASTRAZENECA PHARMA's quarterly results.

ASTRAZENECA PHARMA 2017-18 Annual Report Analysis (Annual Result Update)

Mar 29, 2019 | Updated on Mar 29, 2019

Here's an analysis of the annual report of ASTRAZENECA PHARMA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of ASTRAZENECA PHARMA. Also includes updates on the valuation of ASTRAZENECA PHARMA.

More Views on News

Most Popular

This Crorepati Stock Could Be the Best Vaccine for Your Portfolio Against Coronavirus (Profit Hunter)

Mar 17, 2020

If there is one stock I had to recommend you amid Coronavirus outbreak, this would be it.

If I Were to Recommend One Stock Amid Coronavirus Outbreak, This Would be It. (Profit Hunter)

Mar 19, 2020

Coronavirus outbreak has made no impact on the long term prospects of my favourite smallcap. What it has indeed done is brought the company below my buy price, making it even more attractive investment at current price.

Why India Will Be the Biggest Winner in a Post-Coronavirus World (The 5 Minute Wrapup)

Mar 19, 2020

The way businesses operate will change in a major way post the coronavirus impact. Here's why India stands to benefit from this change...

A Big Trading Opportunity is Coming Your Way Soon (Fast Profits Daily)

Mar 25, 2020

I see a big opportunity to make fast profits on the horizon.

The Real Long-Term Impact of the Coronavirus on India (The 5 Minute Wrapup)

Mar 18, 2020

My view on the impact of the Coronavirus on the Indian economy.

More

How to Trade the
Coronavirus Crash

Coronavirus Crash
Get this special report, authored by Equitymaster's top analysts, now.
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

How to Trade the Coronavirus Crash - Download this FREE Report Now
How to Profit Even During These Times of Crisis: Vijay Bhambwani Reveals his Strategy...
The Best Stocks For 2020 - How to Spot Multibagger Ideas. FREE Sign up!
Free Report: The Secret to Increasing Your Trading Profits Daily!
Find Out Our Top 7 Bluechips for 2020 Virtually FREE. Click Here Now!

ASTRAZENECA PHARMA SHARE PRICE


Mar 27, 2020 (Close)

TRACK ASTRAZENECA PHARMA

  • Track your investment in ASTRAZENECA PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ASTRAZENECA PHARMA

ASTRAZENECA PHARMA 8-QTR ANALYSIS

COMPARE ASTRAZENECA PHARMA WITH

OTHER USEFUL LINKS

MARKET STATS